Zhu et al. [194], in their prospective study population of 86 consecutive patients with AP, they verified that for a cut-off of 25 ng/mL ICAM-1 was a good marker for distinguishing mild from severe AP, with a sensitivity and specificity of 61.1% and 71.4%, respectively. This evidence concerns the gene ICAM1 and alkaline phosphatase measurement.